University of Groningenfounded in 1614  -  top 100 university
Close
About usHow to find usprof. dr. M.J. (Maarten) Postma

prof. dr. M.J. (Maarten) Postma

Professor Dept of Pharmacy & 2ndary appointment Professor UMCG

prof. dr. M.J. (Maarten) Postma
Telephone:
+31 50 36 37576 (secretary)
E-mail:
m.j.postma rug.nl

Research

Research units:

Advanced
Advanced

Reset

to
1 - 50 out of 652Page size: 50
  1. 2019
  2. Arifin, B., van Asselt, A. D. I., Setiawan, D., Atthobari, J., Postma, M. J., & Cao, Q. (2019). Diabetes distress in Indonesian patients with type 2 diabetes: a comparison between primary and tertiary care. BMC Health Services Research, 19(1), [773]. https://doi.org/10.1186/s12913-019-4515-1
  3. van Aalst, R., Gravenstein, S., Mor, V., Mahmud, S. M., Wilschut, J., Postma, M., & Chit, A. (2019). Comparative effectiveness of high dose versus adjuvanted influenza vaccine: A retrospective cohort study. Vaccine. https://doi.org/10.1016/j.vaccine.2019.09.105
  4. Zeevat, F., van der Schans, J., Boersma, W. G., Boersma, C., & Postma, M. J. (2019). Cost-effectiveness analysis on elderly pneumococcal vaccination in the Netherlands: Challenging the Dutch Health Council's advice. Vaccine, 37(43), 6282-6284. https://doi.org/10.1016/j.vaccine.2019.08.051
  5. van der Pol, S., de Jong, L. A., Vemer, P., Jansen, D. E. M. C., & Postma, M. (2019). Cost-Effectiveness of Sacubitril/Valsartan in Germany: An Application of the Efficiency Frontier. Value in Health, 22(10), 1119-1127. https://doi.org/10.1016/j.jval.2019.06.007
  6. Fens, T., van der Pol, S., Kocks, J. W. H., Postma, M. J., & van Boven, J. F. M. (2019). Economic Impact of Reducing Inappropriate Inhaled Corticosteroids Use in Patients With Chronic Obstructive Pulmonary Disease: ISPOR’s guidance on budget impact in practice . Value in Health, 22(10), 1092-1101. https://doi.org/10.1016/j.jval.2019.05.006
  7. Global Burden of Disease Cancer Collaboration (2019). Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017: A Systematic Analysis for the Global Burden of Disease Study. JAMA oncology. https://doi.org/10.1001/jamaoncol.2019.2996
  8. Arifin, B., Probandari, A., Purba, A. K. R., Perwitasari, D. A., Schuiling-Veninga, C. C. M., Atthobari, J., ... Postma, M. J. (2019). 'Diabetes is a gift from god' a qualitative study coping with diabetes distress by Indonesian outpatients. Quality of Life Research. https://doi.org/10.1007/s11136-019-02299-2
  9. Gout-Zwart, J. J., de Jong, L. A., Saptenno, L., & Postma, M. J. (2019). Budget Impact Analysis of Metformin Sustained Release for the Treatment of Type 2 Diabetes in The Netherlands. PharmacoEconomics - open. https://doi.org/10.1007/s41669-019-00179-6
  10. van Wijhe, M., de Boer, P. T., de Jong, H. J., van Vliet, H., Wallinga, J., & Postma, M. J. (2019). Trends in governmental expenditure on vaccination programmes in the Netherlands, a historical analysis. Vaccine, 37(38), 5698-5707. https://doi.org/10.1016/j.vaccine.2019.07.097
  11. Claassens, D. M. F., Vos, G. J. A., Bergmeijer, T. O., Hermanides, R. S., van 't Hof, A. W. J., van der Harst, P., ... Ten Berg, J. M. (2019). A Genotype-Guided Strategy for Oral P2Y12 Inhibitors in Primary PCI. New England Journal of Medicine. https://doi.org/10.1056/NEJMoa1907096
  12. van Schoonhoven, A. V., Gout-Zwart, J. J., de Vries, M. J. S., van Asselt, A. D. I., Dvortsin, E., Vemer, P., ... Postma, M. J. (2019). Costs of clinical events in type 2 diabetes mellitus patients in the Netherlands: A systematic review. PLoS ONE, 14(9), [e0221856]. https://doi.org/10.1371/journal.pone.0221856
  13. Jacobs, M. S., van Hulst, M., Adeoye, A. M., Tieleman, R. G., Postma, M. J., & Owolabi, M. O. (2019). Atrial Fibrillation in Africa-An Underreported and Unrecognized Risk Factor for Stroke: A Systematic Review. Global heart, 14(3), 269-279. https://doi.org/10.1016/j.gheart.2019.04.003
  14. Soikkeli, F., Hashim, M., Ouwens, M., Postma, M., & Heeg, B. (2019). Extrapolating Survival Data Using Historical Trial-Based a Priori Distributions. Value in Health, 22(9), 1012-1017. https://doi.org/10.1016/j.jval.2019.03.017
  15. Freriks, R. D., Mierau, J. O., van der Schans, J., Groenman, A. P., Hoekstra, P. J., Postma, M. J., ... Cao, Q. (2019). Cost-Effectiveness of Treatments in Children With Attention-Deficit/Hyperactivity Disorder: A Continuous-Time Markov Modeling Approach. MDM policy & practice, 4(2), 2381468319867629. https://doi.org/10.1177/2381468319867629
  16. FRESH AIR Collaborators, van Gemert, F., de Jong, C., Kirenga, B., Musinguzi, P., Buteme, S., ... van Boven, J. F. M. (2019). Effects and acceptability of implementing improved cookstoves and heaters to reduce household air pollution: a FRESH AIR study. npj Primary Care Respiratory Medicine, 29(1), [32]. https://doi.org/10.1038/s41533-019-0144-8
  17. van Aalst, R., Russo, E. M., Neupane, N., Mahmud, S. M., Mor, V., Wilschut, J., ... Young-Xu, Y. (2019). Economic assessment of a high-dose versus a standard-dose influenza vaccine in the US Veteran population: Estimating the impact on hospitalization cost for cardio-respiratory disease. Vaccine, 37(32), 4499-4503. https://doi.org/10.1016/j.vaccine.2019.06.066
  18. Connolly, M. P., Kotsopoulos, N., Bhatt, A., & Postma, M. J. (2019). Sustainability of public finances: Inclusion of unrelated medical cost only part of the story. European Journal of Health Economics. https://doi.org/10.1007/s10198-019-01075-w
  19. Larmene-Beld, K. H. M., Touwen-Spronk, J., Luttjeboer, J., Taxis, K., & Postma, M. J. (2019). A Cost Minimization Analysis of Ready-to-Administer Prefilled Sterilized Syringes in a Dutch Hospital. Clinical Therapeutics, 41(6), 1139-1150. https://doi.org/10.1016/j.clinthera.2019.04.024
  20. van der Pol, S., Jacobs, M. S., Meijer, K., Piersma-Wichers, M. G., Tieleman, R. G., Postma, M. J., & van Hulst, M. (2019). Perioperative Bridging of Vitamin K Antagonist Treatment in Patients with Atrial Fibrillation: Only a Very Small Group of Patients Benefits. Europace, 21(5), 716–723. [308]. https://doi.org/10.1093/europace/euy308
  21. GBD 2016 Neurology Collaborators, & Postma, M. (2019). Global, regional, and national burden of neurological disorders, 1990-2016: A systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurology, 18(5), 459-480. https://doi.org/10.1016/S1474-4422(18)30499-X
  22. GBD 2016 Stroke Collaborators, & Postma, M. (2019). Global, regional, and national burden of stroke, 1990-2016: A systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurology, 18(5), 439-458. https://doi.org/10.1016/S1474-4422(19)30034-1
  23. Arifin, B., Idrus, L. R., van Asselt, A. D. I., Purba, F. D., Perwitasari, D. A., Thobari, J. A., ... Postma, M. J. (2019). Health-related quality of life in Indonesian type 2 diabetes mellitus outpatients measured with the Bahasa version of EQ-5D. Quality of Life Research, 28(5), 1179-1190. https://doi.org/10.1007/s11136-019-02105-z
  24. Ong, K. J., van Hoek, A. J., Harris, R. J., Figueroa, J., Waters, L., Chau, C., ... Delpech, V. (2019). HIV care cost in England: A cross-sectional analysis of antiretroviral treatment and the impact of generic introduction. Hiv medicine. https://doi.org/10.1111/hiv.12725
  25. de Jong, L. A., Gout-Zwart, J. J., van den Bosch, M., Koops, M., & Postma, M. J. (2019). Rivaroxaban for non-valvular atrial fibrillation and venous thromboembolism in the Netherlands: a real-world data based cost-effectiveness analysis. Journal of Medical Economics, 22(4), 306-318. https://doi.org/10.1080/13696998.2018.1563404
  26. Fitria, N., van Asselt, A. D. I., & Postma, M. J. (2019). Cost-effectiveness of controlling gestational diabetes mellitus: A systematic review. European Journal of Health Economics, 20(3), 407-417. https://doi.org/10.1007/s10198-018-1006-y
  27. Cao, Q., Buskens, E., Hillege, H. L., Jaarsma, T., Postma, M., & Postmus, D. (2019). Stratified treatment recommendation or one-size-fits-all? A health economic insight based on graphical exploration. European Journal of Health Economics, 20(3), 475-482. https://doi.org/10.1007/s10198-018-1013-z
  28. FRESH AIR Collaborators (2019). COPD's early origins in low-and-middle income countries: what are the implications of a false start? npj Primary Care Respiratory Medicine, 29, [6]. https://doi.org/10.1038/s41533-019-0117-y
  29. Wasserman, M. D., Sings, H. L., Wilson, M. R., Postma, M. J., Breton, M-C., McDade, C., & Farkouh, R. A. (2019). Re-Analysis of Modeling a Switch from a 13-Valent to 10-Valent Pneumococcal Conjugate Vaccine in Canada: Leveraging Real-World Experience from Belgium. Infectious diseases and therapy, 8(1), 1-3. https://doi.org/10.1007/s40121-018-0222-1
  30. Terkola, R., Antonanzas, F., & Postma, M. (2019). Stakeholder opinions on value in healthcare. European Journal of Hospital Pharmacy: Science and Practice, 26(2), 79-84. https://doi.org/10.1136/ejhpharm-2017-001295
  31. Sheikh, S., Biundo, E., Courcier, S., Damm, O., Launay, O., Maes, E., ... Begg, N. (2019). Corrigendum to 'A report on the status of vaccination in Europe' [Vaccine 36 (2018) 4979-4992]. Vaccine, 37(10), 1374-1376. https://doi.org/10.1016/j.vaccine.2019.01.038
  32. Wasir, R., Irawati, S., Makady, A., Postma, M., Goettsch, W., Buskens, E., & Feenstra, T. (2019). Use of medicine pricing and reimbursement policies for universal health coverage in Indonesia. PLoS ONE, 14(2), [e0212328]. https://doi.org/10.1371/journal.pone.0212328
  33. Zakiyah, N., van Asselt, A. D. I., Setiawan, D., Cao, Q., Roijmans, F., & Postma, M. J. (2019). Cost-Effectiveness of Scaling Up Modern Family Planning Interventions in Low- and Middle-Income Countries: An Economic Modeling Analysis in Indonesia and Uganda. Applied Health Economics and Health Policy, 17(1), 66-76. https://doi.org/10.1007/s40258-018-0430-6
  34. Global Burden of Disease Self-Harm Collaborators, Naghavi, M., & Postma, M. (2019). Global, regional, and national burden of suicide mortality 1990 to 2016: Systematic analysis for the Global Burden of Disease Study 2016. BMJ (Clinical research ed.), 364, [l94]. https://doi.org/10.1136/bmj.l94
  35. Gout-Zwart, J. J., Olde Hengel, E. H. J., Hoogland, P., & Postma, M. J. (2019). Budget Impact Analysis of a Renal Point-of-Care Test in Dutch Community Pharmacies to Prevent Antibiotic-Related Hospitalizations. Applied Health Economics and Health Policy, 17(1), 55-63. https://doi.org/10.1007/s40258-018-0426-2
  36. Ong, K. J., Checchi, M., Burns, L., Pavitt, C., Postma, M. J., & Jit, M. (2019). Systematic review and evidence synthesis of non-cervical human papillomavirus-related disease health system costs and quality of life estimates. Sexually Transmitted Infections, 95(1), 28-35. https://doi.org/10.1136/sextrans-2018-053606
  37. Rochanathimoke, O., Riewpaiboon, A., Tharmaphornpilas, P., Jiamsiri, S., Thavorncharoensap, M., & Postma, M. J. (2019). Economic burden of rotavirus diarrhea in Thailand: Report from a pilot study on rotavirus vaccination. Vaccine, 37(4), 587-594. https://doi.org/10.1016/j.vaccine.2018.12.013
  38. Mihajlović, J., Hovius, J. W. R., Sprong, H., Bogovič, P., Postma, M. J., & Strle, F. (2019). Cost-effectiveness of a potential anti-tick vaccine with combined protection against Lyme borreliosis and tick-borne encephalitis in Slovenia. Ticks and tick-borne diseases, 10(1), 63-71. https://doi.org/10.1016/j.ttbdis.2018.08.014
  39. GBD 2017 Influenza Collaborators, & Postma, M. (2019). Mortality, morbidity, and hospitalisations due to influenza lower respiratory tract infections, 2017: an analysis for the Global Burden of Disease Study 2017. The Lancet. Respiratory Medicine, 7(1), 69-89. https://doi.org/10.1016/S2213-2600(18)30496-X
  40. de Jong, L. A., Groeneveld, J., Stevanovic, J., Rila, H., Tieleman, R. G., Huisman, M. V., ... van Hulst, M. (2019). Cost-effectiveness of apixaban compared to other anticoagulants in patients with atrial fibrillation in the real-world and trial settings. PLoS ONE, 14(9), [e0222658]. https://doi.org/10.1371/journal.pone.0222658
  41. Machlaurin, A., van der Pol, S., Setiawan, D., van der Werf, T. S., & Postma, M. J. (2019). Health economic evaluation of current vaccination strategies and new vaccines against tuberculosis: a systematic review. Expert review of vaccines, 18(9), 897-911. https://doi.org/10.1080/14760584.2019.1651650
  42. 2018
  43. De Jong, L. A., Gout-Zwart, J. J., Stevanovic, J., Rila, H., Koops, M., Huisman, M. V., & Postma, M. J. (2018). Extended Treatment with Apixaban for Venous Thromboembolism Prevention in the Netherlands: Clinical and Economic Effects. BMJ Open, 2(3), e315-e324. https://doi.org/10.1055/s-0038-1672185
  44. de Boer, P. T., van Lier, A., de Melker, H., van Wijck, A. J. M., Wilschut, J. C., van Hoek, A. J., & Postma, M. J. (2018). Cost-effectiveness of vaccination of immunocompetent older adults against herpes zoster in the Netherlands: a comparison between the adjuvanted subunit and live-attenuated vaccines. BMC Medicine, 16(1), [228]. https://doi.org/10.1186/s12916-018-1213-5
  45. GACD Multi-Morbidity Working Group, Hurst, J. R., Dickhaus, J., Maulik, P. K., Miranda, J. J., Pastakia, S. D., ... Vedanthan, R. (2018). Global Alliance for Chronic Disease researchers' statement on multimorbidity. The Lancet Global Health, 6(12), 1270-1271. https://doi.org/10.1016/S2214-109X(18)30391-7
  46. de Jong, L. A., Koops, M., Gout-Zwart, J. J., Beinema, M. J., Hemels, M. E. W., Postma, M. J., & Brouwers, J. R. B. J. (2018). Trends in direct oral anticoagulant (DOAC) use: Health benefits and patient preference. Netherlands Journal of Medicine, 76(10), 426-430.
  47. GBD 2016 Meningitis Collaborators, Zunt, J. R., Kassebaum, N. J., Blake, N., Glennie, L., Wright, C., ... Postma, M. J. (2018). Global, regional, and national burden of meningitis, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurology, 17(12), 1061-1082. https://doi.org/10.1016/S1474-4422(18)30387-9
  48. Wilson, M. R., Wasserman, M., Jadavji, T., Postma, M., Breton, M-C., Peloquin, F., ... Farkouh, R. (2018). Response to McGirr et al.'s Comment on "Clinical and Economic Impact of a Potential Switch from 13-Valent to 10-Valent Pneumococcal Conjugate Infant Vaccination in Canada". Infectious diseases and therapy, 7(4), 539-543. https://doi.org/10.1007/s40121-018-0221-2
  49. van Rijt, A. M., Dik, J-W. H., Lokate, M., Postma, M. J., & Friedrich, A. W. (2018). Cost analysis of outbreaks with Methicillin-resistant Staphylococcus aureus (MRSA) in Dutch long-term care facilities (LTCF). PLoS ONE, 13(11), [e0208092]. https://doi.org/10.1371/journal.pone.0208092
  50. GBD 2017 Mortality Collaborators (2018). Global, regional, and national age-sex-specific mortality and life expectancy, 1950-2017: a systematic analysis for the Global Burden of Disease Study 2017. LANCET, 392(10159), 1684-1735. https://doi.org/10.1016/S0140-6736(18)31891-9
  51. Roth, G. A., Collaborotors, G. B. D. C. D., Abate, D., Abate, K. H., Abay, S. M., Abbafati, C., ... Postma, M. J. (2018). Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017. LANCET, 392(10159), 1736-1788. https://doi.org/10.1016/S0140-6736(18)32203-7
  52. Stanaway, J. D., Afshin, A., Gakidou, E., Lim, S. S., Abate, D., Abate, K. H., ... Zhang, H. (2018). Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. LANCET, 392(10159), 1923-1994. https://doi.org/10.1016/S0140-6736(18)32225-6
Previous 1 2 3 4 5 6 7 8 ...14 Next

ID: 193217

University of Groningen staff: edit these data

print
Follow the UGfacebook twitter linkedin rss instagram youtube